healthneutral
Exploring APE1/Ref-1: A New Approach to Fight Duchenne
Friday, December 27, 2024
We know it's involved in other disorders, and blocking its redox function with a small molecule called APX3330 seems to help. But, we need to figure out if APE1/Ref-1 is a friend or foe in skeletal muscle. Is it too active or not active enough in conditions like Duchenne? Answering these questions could lead to new ways to tackle chronic inflammation and oxidative stress.
Actions
flag content